US approval for haemophilia drug derived from genetically engineered rabbit’s milk
April 2, 2020Sales and Marketing FDA, US, haemophilia, pharma
The FDA has announced the approval of Sevenfact, a haemophilia therapy the active ingredient from which is expressed in genetically …
FDA places no penalties on Novartis after Zolgensma data manipulation investigation
April 2, 2020Business Services FDA, Novartis, regulators
The FDA has concluded its investigation into Novartis and its data manipulation of the gene therapy Zolgensma, and has decided …
EUSA Pharma’s COVID-19 drug improves or stabilises respiratory condition in 76% of patients
April 2, 2020Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, siltuximab
EUSA Pharma has unveiled promising preliminary findings from an interim analysis of siltuximab in the treatment of serious respiratory complications …
British American Tobacco creating coronavirus vaccine
April 2, 2020Business Services COVID-19, coronavirus
British American Tobacco has said it is developing a COVID-19 vaccine from tobacco plants. The owner of famous cigarette brands, …
Researchers modify T-cells to identify and target multiple sites on leukaemia cells
April 1, 2020Research and Development Cancer, Cancers, children cancer, leukaemia
Scientists from the Children’s Hospital of Los Angeles have engineered T-cells to identify and target multiple sites on acute lymphoblastic …
The April 2020 issue of Pharmafocus is available to read free online now!
April 1, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, UK, US, coronavirus, generic medicines, pharma, rare disease, real world data, real-world data
The latest monthly edition of Pharmafocus, the April 2020 issue, is available to read for free online now! There’s one …
FDA aims to accelerate COVID-19 therapies with new programme
April 1, 2020Research and Development COVID-19, FDA, america, coronaviurs
The FDA has launched the Coronavirus Treatment Acceleration Program (CTAP) to quickly bring therapies and treatments to people suffering from …
Europe sells Iran medicine, defying US sanctions
April 1, 2020Research and Development Iran, Iran Sanctions, Iran US, USA, coronavirus
France, Germany and the UK have announced the sale of medicinal goods to Iran, bypassing US sanctions on the country …
Lilly partners with Sitryx in $880m immunometabolism drug development deal
April 1, 2020Research and Development Eli Lilly, Sitryx, partnership, pharma
Eli Lilly and UK firm Sitryx have partnered up in a new drug development and commercialisation deal that could potentially …
Axsome’s late-stage study of experimental depression drug misses main trial goal
March 31, 2020Manufacturing and Production Depressive Disorder, MDD, depression, migraine
Axsome Therapeutics reported on Monday that its Phase 3 study of its experimental depression drug missed its main trial goal. …
Johnson & Johnson selects lead COVID-19 vaccine candidate and targets September Phase I study
March 31, 2020Manufacturing and Production . Johnson & Johnson, Johnson & Johnson, Vaccine, coronavirus, coronavirus vaccine
Johnson & Johnson announced that it has selected a candidate for a COVID-19 vaccine from potential constructs it has been …
Bayer’s Nubeqa combo approved in Europe for non-metastatic castration-resistant prostate cancer
March 31, 2020Manufacturing and Production, Research and Development Bayer, Cancer, Europe, Nubeqa, prostate cancer
The European Commission has given the green light to Bayer’s non-steroidal androgen receptor inhibitor Nubeqa (darolutamide), jointly developed with Orion, …
UK social distancing measures making a difference to the spread of COVID-19, government says
March 31, 2020Manufacturing and Production British Coronavirus, COVID-`9, coronavirus, coronavirus uk
Social distancing measures are slowing down the spread of coronavirus and keeping pressure off the NHS, according to the UK’s …
EUSA Pharma and Ergomed partner to investigate IL-6 targeting in COVID-19 patients with serious respiratory complications
March 31, 2020Manufacturing and Production, Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, pharma
Oncology and rare disease firm EUSA Pharma is aiding in the global fight against the novel coronavirus with the launch …
People or profit: What is the best system to regulate drug prices?
March 30, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Conor Kavanagh investigates the role state healthcare institutions play in negotiating drug prices, and what steps can be taken for …
FDA immunotherapy first with the approval of AZ’s Imfinzi in first-line extensive-stage small cell lung cancer
March 30, 2020Sales and Marketing AstraZeneca, Cancer, FDA, Imfinzi, lung cancer, pharma
AstraZeneca has seized FDA approval for its immune checkpoint inhibitor Imfinzi (durvalumab) in the first-line treatment of extensive-stage small cell …
EMA gives market authorisation application to epilepsy treatment from Arvelle Therapeutics
March 30, 2020Sales and Marketing EMA, EMA approvals, approvals, epilepsy
The European Medicines Agency (EMA) has accepted a marketing authorisation application (MAA) for a cenobamate adjunctive treatment of focal-onset seizures …
Sanofi agrees a second partnership to develop a COVID-19 vaccine
March 30, 2020Sales and Marketing Vaccine, china coronavirus, coronavirus, coronavirus vaccine
Sanofi has partnered with Translate Bio to develop a novel messenger RNA (mRNA) vaccine for COVID-19 while they are also …
WHO launches “historic” multinational study to investigate most promising COVID-19 therapies
March 30, 2020Research and Development, Sales and Marketing COVID-19, Gilead, coronavirus, pharma, remdesivir
The World Health Organization continues to push forward in the global fight against the novel coronavirus, and has announced the …
Hydroxychloroquine given to 1,100 patients with COVID-19 in New York
March 30, 2020Sales and Marketing COVID-19, New York, china coronavirus, coronavirus
The malaria drug hydroxychloroquine is being administered to 1,100 patients in New York, which is fast becoming the new epicenter …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
